
X
LEO Pharma acquires Bayer’s dermatology unit
https://pharmaphorum.com/news/leo-pharma-acquires-bayers-dermatology-unit/
The US FDA has approved a label extension for UCB’s Cimzia (certolizumab pegol) for adults with moderate-to-severe plaque psoriasis
Join The Microbiome Movement
Immune disorder drug is highlight of pipeline
But NICE rejects Dupixent in eczema